United States Patient At Home Testing Kits Market By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, COVID-19 Testing, Others), By Sample (Blood, Urine, Saliva), By Usage (Disposable v/s Reusable), By Distribution Channel (Retail Pharmacy Stores, Hypermarket/Supermarket, E-Commerce) By Region, Competition Forecast & Opportunities, 2026
United States patient at home testing kits market stood at USD3239.54 million in 2020 and is expected to grow at a CAGR of 7.94% during the forecast period on account of growing awareness among the population for early disease diagnosis and preventive healthcare. Besides, benefits associated with at home testing kits such as ease of use, convenience in testing, affordability, easy availability, among others are expected to drive the market growth during the forecast period. The sudden outbreak and spread of the COVID-19 pandemic has significantly boosted the market growth owing to the launch of at home testing kits by many players in the United States and their widespread use in COVID-19 testing. Furthermore, technological advancements such as incorporation of Bluetooth into COVID-19 testing kits, digital pregnancy kits, among others are expected to create lucrative opportunities for the market growth over the next few years.
The United States patient at home testing kits market can be segmented into test type, sample, usage, distribution channel, region and company. Based on test type, the market can be categorized into blood glucose testing, pregnancy & fertility testing, cholesterol testing, urine testing, COVID-19 testing, among others. The blood glucose testing segment is expected to dominate the market in 2020 with an overall market share of around 39.17% and is expected to continue its dominance through the forecast period. This can be ascribed to the ever-increasing diabetic population in the United States. United States is home to the third-largest diabetic population in the world. While the cholesterol testing segment is also expected to witness significant growth during the forecast period. This can be ascribed to the growing prevalence of cardiovascular diseases in the country. However, the sudden outbreak and spread of the COVID-19 pandemic led to the development and launch of several at home COVID-19 testing kits. The growing cases of COVID-19 and United States being significantly hit by the pandemic further increased the demand for at home COVID-19 testing kits. On the other hand, pregnancy testing kits are one of the regularly used at home testing kits which have been used by women across the world.
The United States patient at home testing kits markets is highly fragmented with a lot of well-established players in the industry, few emerging players and even few players from other parts of the world. Major players operating in the United States patient at home testing kits market include Lucira Health Inc., Essenlix Corporation, Abbott Laboratories, Inc., Roche Diagnostics Corporation, Siemens Medical Solutions USA, Inc., Thermo Fischer Scientific, Inc., Scanwell Health, Inc., Quidel Corporation, GE Healthcare, Inc., ACON Laboratories, Inc., among others. The market has witnessed a lot of players emerging out during the pandemic which have entered the market by launching their at home COVID-19 testing kits. For instance, Lucira Health, Inc. received the very first approval for patient at home COVID-19 testing kit.
Years considered for this report:
TechSci Research calculated the market size of United States patient at home testing kits market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
Report Scope:
In this report, United States patient at home testing kits market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in United States patient at home testing kits market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
The United States patient at home testing kits market can be segmented into test type, sample, usage, distribution channel, region and company. Based on test type, the market can be categorized into blood glucose testing, pregnancy & fertility testing, cholesterol testing, urine testing, COVID-19 testing, among others. The blood glucose testing segment is expected to dominate the market in 2020 with an overall market share of around 39.17% and is expected to continue its dominance through the forecast period. This can be ascribed to the ever-increasing diabetic population in the United States. United States is home to the third-largest diabetic population in the world. While the cholesterol testing segment is also expected to witness significant growth during the forecast period. This can be ascribed to the growing prevalence of cardiovascular diseases in the country. However, the sudden outbreak and spread of the COVID-19 pandemic led to the development and launch of several at home COVID-19 testing kits. The growing cases of COVID-19 and United States being significantly hit by the pandemic further increased the demand for at home COVID-19 testing kits. On the other hand, pregnancy testing kits are one of the regularly used at home testing kits which have been used by women across the world.
The United States patient at home testing kits markets is highly fragmented with a lot of well-established players in the industry, few emerging players and even few players from other parts of the world. Major players operating in the United States patient at home testing kits market include Lucira Health Inc., Essenlix Corporation, Abbott Laboratories, Inc., Roche Diagnostics Corporation, Siemens Medical Solutions USA, Inc., Thermo Fischer Scientific, Inc., Scanwell Health, Inc., Quidel Corporation, GE Healthcare, Inc., ACON Laboratories, Inc., among others. The market has witnessed a lot of players emerging out during the pandemic which have entered the market by launching their at home COVID-19 testing kits. For instance, Lucira Health, Inc. received the very first approval for patient at home COVID-19 testing kit.
Years considered for this report:
- Historical Years: 2016 – 2019
- Base Year: 2020
- Estimated Year: 2021
- Forecast Period: 2022 – 2026
- To analyze the historical growth of the market size of United States patient at home testing kits market from 2016 to 2020.
- To estimate and forecast the market size of United States patient at home testing kits market from 2021 to 2026 and growth rate until 2026.
- To classify and forecast United States patient at home testing kits market based on test type, sample, usage, distribution channel, company, and regional distribution.
- To identify the dominant region or segment in the United States patient at home testing kits market.
- To identify drivers and challenges for United States patient at home testing kits market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States patient at home testing kits market.
- To identify and analyze the profile of leading players operating in United States patient at home testing kits market.
- To identify key sustainable strategies adopted by market players in United States patient at home testing kits market.
TechSci Research calculated the market size of United States patient at home testing kits market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Patient at home testing kits manufacturers, end users, and other stakeholders
- Distributors and suppliers of the products and other stakeholders
- Organizations, forums, and alliances related to patient at home testing kits products
- Market research and consulting firms
Report Scope:
In this report, United States patient at home testing kits market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- United States Patient At Home Testing Kits Market, By Test Type:
- Blood Glucose Testing
- Pregnancy & Fertility Testing
- Cholesterol Testing
- Urine Testing
- COVID-19 Testing
- Others
- United States Patient At Home Testing Kits Market, By Sample:
- Blood
- Urine
- Saliva
- United States Patient At Home Testing Kits Market, By Usage:
- Disposable
- Reusable
- United States Patient At Home Testing Kits Market, By Distribution Channel:
- Retail Pharmacy Stores
- Hypermarket/Supermarket
- E-Commerce
- United States Patient At Home Testing Kits Market, By Region:
- South
- Mid-West
- North-East
- West
Company Profiles: Detailed analysis of the major companies present in United States patient at home testing kits market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UNITED STATES PATIENT AT HOME TESTING KITS MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMERS
5.1. Brand Awareness
5.2. Preferences of At Home Testing Kits Across Gender
5.3. Sources of Information
5.4. Factors Influencing Purchase Decision for At Home Testing Kits
6. UNITED STATES PATIENT AT HOME TESTING KITS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, COVID-19 Testing, Others)
6.2.2. By Sample (Blood, Urine, Saliva)
6.2.3. By Usage (Disposable v/s Reusable)
6.2.4. By Distribution Channel (Retail Pharmacy Stores, Hypermarket/Supermarket, E-Commerce)
6.2.5. By Region
6.2.6. By Company (2020)
6.3. Market Map
6.3.1. By Usage
6.3.2. By Distribution Channel
7. UNITED STATES DISPOSABLE PATIENT AT HOME TESTING KITS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By Sample
7.2.3. By Distribution Channel
8. UNITED STATES REUSABLE PATIENT AT HOME TESTING KITS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By Sample
8.2.3. By Distribution Channel
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
11. POLICY & REGULATORY LANDSCAPE
12. IMPORT-EXPORT ANALYSIS
13. UNITED STATES ECONOMIC PROFILE
14. COMPETITIVE LANDSCAPE
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Lucira Health Inc.
14.2.2. Essenlix Corporation
14.2.3. Abbott Laboratories, Inc.
14.2.4. Roche Diagnostics Corporation
14.2.5. Siemens Medical Solutions USA, Inc.
14.2.6. Thermo Fischer Scientific, Inc.
14.2.7. Scanwell Health, Inc.
14.2.8. Quidel Corporation
14.2.9. GE Healthcare, Inc.
14.2.10. ACON Laboratories, Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UNITED STATES PATIENT AT HOME TESTING KITS MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMERS
5.1. Brand Awareness
5.2. Preferences of At Home Testing Kits Across Gender
5.3. Sources of Information
5.4. Factors Influencing Purchase Decision for At Home Testing Kits
6. UNITED STATES PATIENT AT HOME TESTING KITS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, COVID-19 Testing, Others)
6.2.2. By Sample (Blood, Urine, Saliva)
6.2.3. By Usage (Disposable v/s Reusable)
6.2.4. By Distribution Channel (Retail Pharmacy Stores, Hypermarket/Supermarket, E-Commerce)
6.2.5. By Region
6.2.6. By Company (2020)
6.3. Market Map
6.3.1. By Usage
6.3.2. By Distribution Channel
7. UNITED STATES DISPOSABLE PATIENT AT HOME TESTING KITS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By Sample
7.2.3. By Distribution Channel
8. UNITED STATES REUSABLE PATIENT AT HOME TESTING KITS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By Sample
8.2.3. By Distribution Channel
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
11. POLICY & REGULATORY LANDSCAPE
12. IMPORT-EXPORT ANALYSIS
13. UNITED STATES ECONOMIC PROFILE
14. COMPETITIVE LANDSCAPE
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Lucira Health Inc.
14.2.2. Essenlix Corporation
14.2.3. Abbott Laboratories, Inc.
14.2.4. Roche Diagnostics Corporation
14.2.5. Siemens Medical Solutions USA, Inc.
14.2.6. Thermo Fischer Scientific, Inc.
14.2.7. Scanwell Health, Inc.
14.2.8. Quidel Corporation
14.2.9. GE Healthcare, Inc.
14.2.10. ACON Laboratories, Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
LIST OF TABLES
Table 1: United States COVID-19 Statistics, As of 8th September, 2021
Table 2: United States COVID-19 Statistics, By State, As of 8th September, 2021
Table 1: United States COVID-19 Statistics, As of 8th September, 2021
Table 2: United States COVID-19 Statistics, By State, As of 8th September, 2021
LIST OF FIGURES
Figure 1: United States Patient At Home Testing Kits Market Size, By Value (USD Million), 2016-2026F
Figure 2: United States Patient At Home Testing Kits Market Share, By Test Type, By Value, 2016-2026F
Figure 3: United States Birth Rate (Per 1,000 inhabitants), 2016-2019
Figure 4: United States Patient At Home Testing Kits Market Share, By Sample, By Value, 2016-2026F
Figure 5: United States Patient At Home Testing Kits Market Share, By Usage, By Value, 2016-2026F
Figure 6: United States Patient At Home Testing Kits Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 7: United States Patient At Home Testing Kits Market Share, By Region, By Value, 2016-2026F
Figure 8: United States Patient At Home Testing Kits Market Share, By Company, By Value, 2020
Figure 9: United States Patient At Home Testing Kits Market Map, By Usage, Market Size (USD Million) & Growth Rate (%), 2020
Figure 10: United States Patient At Home Testing Kits Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2020
Figure 11: United States Disposable Patient At Home Testing Kits Market Size, By Value (USD Million), 2016-2026F
Figure 12: United States National Per Capita Healthcare Expenditure (USD), 2016-2020
Figure 13: United States Disposable Patient At Home Testing Kits Market Share, By Test Type, By Value, 2016-2026F
Figure 14: United States Disposable Patient At Home Testing Kits Market Share, By Sample, By Value, 2016-2026F
Figure 15: United States Disposable Patient At Home Testing Kits Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 16: Number of Leading Drug Stores in the United States, 2020
Figure 17: United States Reusable Patient At Home Testing Kits Market Size, By Value (USD Million), 2016-2026F
Figure 18: United States National Health Expenditure as a Percentage of GDP, 2016-2020
Figure 19: United States Reusable Patient At Home Testing Kits Market Share, By Test Type, By Value, 2016-2026F
Figure 20: United States Reusable Patient At Home Testing Kits Market Share, By Sample, By Value, 2016-2026F
Figure 21: Leading Causes of Death in United States in 2020 (per 100,000 Population)
Figure 22: United States Reusable Patient At Home Testing Kits Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 23: Net Revenue Generated by Top 3 Online Pharmacies 2019
Figure 24: United States Imports of Diagnostic or Laboratory Reagents, By Value (USD Million), 2016-2020
Figure 25: United States Exports of Diagnostic or Laboratory Reagents, By Value (USD Million), 2016-2020
Figure 1: United States Patient At Home Testing Kits Market Size, By Value (USD Million), 2016-2026F
Figure 2: United States Patient At Home Testing Kits Market Share, By Test Type, By Value, 2016-2026F
Figure 3: United States Birth Rate (Per 1,000 inhabitants), 2016-2019
Figure 4: United States Patient At Home Testing Kits Market Share, By Sample, By Value, 2016-2026F
Figure 5: United States Patient At Home Testing Kits Market Share, By Usage, By Value, 2016-2026F
Figure 6: United States Patient At Home Testing Kits Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 7: United States Patient At Home Testing Kits Market Share, By Region, By Value, 2016-2026F
Figure 8: United States Patient At Home Testing Kits Market Share, By Company, By Value, 2020
Figure 9: United States Patient At Home Testing Kits Market Map, By Usage, Market Size (USD Million) & Growth Rate (%), 2020
Figure 10: United States Patient At Home Testing Kits Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2020
Figure 11: United States Disposable Patient At Home Testing Kits Market Size, By Value (USD Million), 2016-2026F
Figure 12: United States National Per Capita Healthcare Expenditure (USD), 2016-2020
Figure 13: United States Disposable Patient At Home Testing Kits Market Share, By Test Type, By Value, 2016-2026F
Figure 14: United States Disposable Patient At Home Testing Kits Market Share, By Sample, By Value, 2016-2026F
Figure 15: United States Disposable Patient At Home Testing Kits Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 16: Number of Leading Drug Stores in the United States, 2020
Figure 17: United States Reusable Patient At Home Testing Kits Market Size, By Value (USD Million), 2016-2026F
Figure 18: United States National Health Expenditure as a Percentage of GDP, 2016-2020
Figure 19: United States Reusable Patient At Home Testing Kits Market Share, By Test Type, By Value, 2016-2026F
Figure 20: United States Reusable Patient At Home Testing Kits Market Share, By Sample, By Value, 2016-2026F
Figure 21: Leading Causes of Death in United States in 2020 (per 100,000 Population)
Figure 22: United States Reusable Patient At Home Testing Kits Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 23: Net Revenue Generated by Top 3 Online Pharmacies 2019
Figure 24: United States Imports of Diagnostic or Laboratory Reagents, By Value (USD Million), 2016-2020
Figure 25: United States Exports of Diagnostic or Laboratory Reagents, By Value (USD Million), 2016-2020
